Cure My Disease

Don't miss your cure!

 Log in / Sign up

Lawyers and pharmacists team up to help coal miners kick tobacco

NCT ID NCT07694492

Not yet recruiting Disease control Sponsor: University of Virginia Source: ClinicalTrials.gov ↗

First seen Jul 10, 2026 · Last updated Jul 10, 2026

Summary

Coal miners in Central Appalachia use tobacco at very high rates and face serious lung diseases like cancer and black lung. This study tests a new approach: lawyers handling black-lung compensation cases identify miners who use tobacco and connect them to community pharmacists. The pharmacists provide coaching sessions and nicotine replacement therapy (patches or gum) to help them quit. The study is a small pilot to see if this referral process works and how well miners stick with the program.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Nicotine replacement therapy (patch or gum) and pharmacist coaching sessions
What this could lead to
If successful, this approach could help coal miners quit tobacco, reducing their high risk of lung cancer and black-lung disease.
What could go wrong
This is a small feasibility pilot, not designed to prove the program works. Results may not apply to other groups or settings.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for NICOTINE DEPENDENCE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

anthracosis nicotine dependence Smoking Cessation Tobacco Use Cessation

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

NICOTINE DEPENDENCE SMOKELESS TOBACCO USE TOBACCO USE CESSATION TOBACCO USE DISORDER

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • University of Virginia

    Charlottesville, Virginia, 22903, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

    Contact

    Contact

    Contact

More trials for these conditions

Other studies related to the condition(s) this trial covers.